Parathyroid Hormone-related Peptide (PTH-rP) Test
Parathyroid Hormone-related Peptide (PTH-rP) Test
The Parathyroid Hormone-related Peptide (PTH-rP) Test measures the levels of PTH-rP, a protein that plays a crucial role in calcium regulation and bone metabolism. Although it functions similarly to parathyroid hormone (PTH), PTH-rP is primarily associated with humoral hypercalcemia of malignancy (HHM), a condition where tumors secrete excess PTH-rP, leading to elevated blood calcium levels (hypercalcemia).
PTH-rP is normally involved in various physiological processes, including:
- Fetal development, where it regulates calcium transport across the placenta.
- Lactation, where it helps mobilize calcium for breast milk production.
- Bone remodeling, by influencing osteoblast and osteoclast activity.
However, in cancerous conditions, excessive PTH-rP production can lead to severe hypercalcemia, kidney damage, and neurological symptoms. Common malignancies associated with high PTH-rP levels include lung cancer, breast cancer, renal cell carcinoma, and multiple myeloma. Differentiating between malignancy-induced hypercalcemia and primary hyperparathyroidism is critical for proper diagnosis and treatment.
What is the PTH-rP Test Used For?
This test is used to:
- Diagnose humoral hypercalcemia of malignancy (HHM).
- Differentiate between primary hyperparathyroidism and malignancy-related hypercalcemia.
- Monitor calcium-related disorders in cancer patients.
- Assess abnormal bone metabolism or paraneoplastic syndromes.
Symptoms of Abnormal Parathyroid Hormone-related Peptide Levels
Abnormal Parathyroid Hormone-related Peptide (PTHrP) levels are often associated with malignancy and can lead to hypercalcemia of malignancy or other metabolic disturbances.
Excessive thirst & frequent urination (polyuria, polydipsia)
Nausea, vomiting, & constipation
Fatigue & muscle weakness
Confusion, memory loss, or irritability
Bone pain or fractures (due to increased bone resorption)
Kidney stones
Preparation for the Test
Fasting is not required. A blood sample is drawn from a vein for analysis. Avoid calcium supplements or vitamin D before testing, as they can affect calcium metabolism. Inform your doctor about medications that influence calcium levels, such as diuretics or bisphosphonates.
Interpretation of Results
- Elevated PTH-rP (>2.5 pmol/L)- Strongly suggests cancer-associated hypercalcemia.
- Low or Normal PTH-rP (<1.5 pmol/L)- Indicates primary hyperparathyroidism or other non-malignant causes.
- High PTH with low/normal PTH-rP- Suggests primary hyperparathyroidism rather than cancer.
FAQs
How is hypercalcemia due to PTH-rP treated?
Treatment involves hydration, bisphosphonates, and addressing the underlying cancer.
Is PTH-rP always associated with cancer?
Mostly, but rare non-malignant conditions can also cause mild PTH-rP elevation.
How is this test different from a PTH test?
- PTH-rP is linked to cancer-related hypercalcemia.
- PTH measures parathyroid gland function.
Can PTH-rP levels be lowered?
Treating the underlying malignancy is the most effective way to lower PTH-rP levels.
What other tests may be done with PTH-rP?
- Serum Calcium & Ionized Calcium
- Parathyroid Hormone (PTH) Test
- Vitamin D Levels
- Bone Scan (if bone metastases are suspected)
Related tests
Tests At Lupin Diagnostics